Skip to main content
PMC home page
Japanese Journal of Cancer Research : Gann logoLink to Japanese Journal of Cancer Research : Gann
. 2002 Oct;93(10):1107–1113. doi: 10.1111/j.1349-7006.2002.tb01212.x

Frequent Epigenetic Silencing of the p16 Gene in Non‐small Cell Lung Cancers of Tobacco Smokers

Naoki Yanagawa 1,2, Gen Tamura 1,✉, Hiroyuki Oizumi 2, Nobumasa Takahashi 2, Yasuhisa Shimazaki 2, Teiichi Motoyama 1
PMCID: PMC5926878  PMID: 12417040

Abstract

Epidemiological studies have demonstrated a causal link between tobacco smoking and lung cancer. We investigated the association between inactivation of the p16 gene and tobacco smoking in 51 non‐small cell lung cancers (NSCLCs). Aberrations of the p16 gene were studied by PCR single‐strand conformation polymorphism analysis, followed by direct sequencing, microsatellite analysis, methylation‐specific PCR, and immunohistochemistry. Mutations were detected in 3.9% (2/51) of the tumors; the tumors carrying mutations were from smokers. The incidences of loss of heterozygosity, homozygous deletion, and promoter methylation in 37 smokers vs. 14 non‐smokers were; 45.9% vs. 28.6%, 16.2% vs. 7.1%, and 35.1% vs. 7.1%, respectively. Among these, only the association between promoter methylation and tobacco smoking was statistically significant (P<0.05). Therefore, epigenetic aberration is considered to be a major causative event in p16 silencing by tobacco smoking. Loss of p16 protein expression was apparent in 49% (25/51) of the tumors, and was associated with tobacco smoking (P<0.05) and with histological type (P<0.05). These findings suggest that tobacco smoking leads to inactivation of the p16 gene mainly through the epigenetic mechanism, ultimately increasing the risk of NSCLC, especially the squamous cell histological type.

Keywords: p16 gene, Non‐small cell lung cancer, Tobacco smoking, Promoter methylation

Full Text

The Full Text of this article is available as a PDF (508.5 KB).

REFERENCES

  • 1. ) Rom , W. N. , Hay , J. G. , Lee , T. C. , Jiang , Y. and Tchouwong , K.Molecular and genetic aspects of lung cancer . Am. J. Respir. Crit. Care Med. , 161 , 1355 – 1367 ( 2000. ). [DOI] [PubMed] [Google Scholar]
  • 2. ) Belinsky , S. A. , Nikula , K. J. , Palmisano , W. A. , Micheles , R. , Saccomanno , G. , Gabrielson , E. , Baylin , S. B. and Herman , J. G.Aberrant methylation of pl6INK4A is an early event in lung cancer and a potential marker for early diagnosis . Proc. Nad. Acad. Sci. USA , 95 , 11891 – 11896 ( 1998. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. ) Kim , D. H. , Nelson , H. H. , Wiencke , J. K. , Zheng , S. , Christiani , D. C. , Wain , J. C. , Mark , E. J. and Kelsey , K. T.p16INK4a and histology‐specific methylation of CpG islands by exposure to tobacco smoke in non‐small cell lung cancer . Cancer Res. , 61 , 3419 – 3424 ( 2001. ). [PubMed] [Google Scholar]
  • 4. ) Greenblatt , M. S. , Bennett , W. P. , Hollstein , M. and Harris , C. C.Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis . Cancer Res. , 54 , 4855 – 4878 ( 1994. ). [PubMed] [Google Scholar]
  • 5. ) Denissenko , M. F. , Pao , A. , Tang , M. and Pfeifer , G. P.Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in p53 . Science , 274 , 430 – 432 ( 1996. ). [DOI] [PubMed] [Google Scholar]
  • 6. ) Esposito , V. , Baldi , A. , De Luca , A. , Micheli , P. , Mazzarella , G. , Baldi , F. , Caputi , M. and Giordano , A.Prognostic value of p53 in non‐small cell lung cancer: relationship with proliferating cell nuclear antigen and cigarette smoking . Hum. Pathol. , 28 , 233 – 237 ( 1997. ). [DOI] [PubMed] [Google Scholar]
  • 7. ) Tammemagi , M. C. , McLaughlin , J. R. and Bull , S. B.Meta‐analysis of p53 tumor suppressor gene alterations and clinicopathological features in resected lung cancers . Cancer Epidemiol. Biomarkers Prev. , 8 , 625 – 634 ( 1999. ). [PubMed] [Google Scholar]
  • 8. ) Sozzi , G. , Sard , L. , de Gregorio , L. , Marchetti , A. , Musso , K. , Buttitta , F. , Tornielli , S. , Pellegrini , S. , Veronese , M. L. , Manenti , G. , Incardone , M. , Chella , A. , Angeletti , C. A. , Pastorino , U. , Huebner , K. , Bevilaqua , G. , Pilotti , S. , Croce , C. M. and Pierotti , M. A.Association between cigarette smoking and FHIT gene alterations in lung cancer . Cancer Res. , 57 , 2121 – 2123 ( 1997. ). [PubMed] [Google Scholar]
  • 9. ) Nelson , H. H. , Christiani , D. C. , Mark , E. J. , Wiencke , J. K. , Wain , J. C. and Kelsey , K. T.Implications and prognostic value of K‐ras mutation for early‐stage lung cancer in women . J. Natl. Cancer Inst. , 91 , 2032 – 2038 ( 1999. ). [DOI] [PubMed] [Google Scholar]
  • 10. ) Cespedes , M. S. , Decker , P. A. , Doffek , K. M. , Esteller , M. , Westra , W. H. , Alawi , E. A. , Herman , J. G. , Demeure , M. J. , Sidransky , D. and Ahrendt , S. A.Increased loss of chromosome 9p21 but not p16 inactivation in primary non‐small cell lung cancer from smokers . Cancer Res. , 61 , 2092 – 2096 ( 2001. ). [PubMed] [Google Scholar]
  • 11. ) Sherr , C. J.G1 phase progression: cycling on cue . Cell , 79 , 551 – 555 ( 1994. ). [DOI] [PubMed] [Google Scholar]
  • 12. ) Weinberg , R. A.The retinoblastoma protein and cell cycle control . Cell , 81 , 323 – 330 ( 1995. ). [DOI] [PubMed] [Google Scholar]
  • 13. ) Serrano , M. , Hannon , G. J. and Beach , D.A new regulatory motif in cell cycle control causing specific inhibition of cyclin D/CDK4 . Nature , 366 , 704 – 707 ( 1993. ). [DOI] [PubMed] [Google Scholar]
  • 14. ) Kamb , A. , Guis , N. A. , Weaver‐Feldhaus , J. , Liu , Q. , Harshman , K. , Tavtigian , S. V. , Stodkert , E. , Day , R. S. , Johns , B. E. and Skolnick , M. H.A cell cycle regulator potentially involved in genesis of many tumor types . Science , 264 , 436 – 440 ( 1994. ). [DOI] [PubMed] [Google Scholar]
  • 15. ) Kratzke , R. A. , Greatens , T. M. , Rubins , J. B. , Maddaus , M. A. , Niewoehner , D. E. , Niehams , G. A. and Geradts , J.Rb and p16INK4A expression in resected non‐small cell lung tumors . Cancer Res. , 56 , 3415 – 3420 ( 1996. ). [PubMed] [Google Scholar]
  • 16. ) Gazzeri , S. , Gouyer , V. , Vour'ch , C. , Brambilla , C. and Brambilla , E.Mechanisms of p16INK4A inactivation in non small‐cell lung cancers . Oncogene , 16 , 497 – 504 ( 1998. ). [DOI] [PubMed] [Google Scholar]
  • 17. ) Cespedes , M. S. , Reed , A. L. , Buta , M. , Wu , L. , Westra , W. H. , Herman , J. G. , Yang , S. C. , Jen , J. and Sidransky , D.Inactivation of the INK4A/ARF locus frequently coexists with TP53 mutations in non‐small cell lung cancer . Oncogene , 18 , 5843 – 5849 ( 1999. ). [DOI] [PubMed] [Google Scholar]
  • 18. ) Nobori , T. , Miura , K. , Wu , D. J. , Lois , A. , Takabayashi , K. and Carson , D.A deletion of the cyclin‐dependent kinase‐4 inhibitor gene in multiple human cancers . Nature , 368 , 753 – 756 ( 1994. ). [DOI] [PubMed] [Google Scholar]
  • 19. ) de Vos , S. , Miller , C. W. , Gombart , A. F. , Cho , S. K. and Koeffler , H. P.Alterations of CDKN2 (p16) in non‐small cell lung cancer . Genes Chromosom. Cancer , 14 , 165 – 170 ( 1995. ). [DOI] [PubMed] [Google Scholar]
  • 20. ) Cairns , P. , Mao , L. , Merlo , A. , Lee , D. J. , Schwab , D. , Eby , Y. , Tokino , K. , van der Riet , P. , Blaugrund , J. E. and Sidransky , D.Rates of p16 (MTS1) mutations in primary tumors with 9p loss . Science , 265 , 415 – 417 ( 1994. ). [DOI] [PubMed] [Google Scholar]
  • 21. ) Okamoto , A. , Hussain , S. P. , Hagiwara , K. , Spillare , E. A. , Rusin , M. R. , Demetrick , D. J. , Serrano , M. , Hannon , G. J. , Shiseki , M. , Zariwala , M. , Xiong , Y. , Beach , D. H. , Yokota , J. and Harris , C. C.Mutations in the p16INK4A/MTS1/CDKN2, p15INK4B/MTS2, and p18 genes in primary and metastatic lung cancer . Cancer Res. , 55 , 1448 – 1451 ( 1995. ). [PubMed] [Google Scholar]
  • 22. ) Merlo , A. , Herman , J. G. , Mao , L. , Lee , D. J. , Gabrielson , E. , Burger , P. C. , Baylin , S. B. and Sidransky , D.5′ CpG island methylation is associated with transcriptional silencing of the tumor suppressor p16/CDKN2/MTS1 in human cancer . Nat. Med. , 1 , 686 – 692 ( 1995. ). [DOI] [PubMed] [Google Scholar]
  • 23. ) Kashiwabara , K. , Oyama , T. , Sano , T. , Fukuda , T. and Nakajima , T.Correlation between methylation status of the p16/CDKN2 gene and the expression of p16 and Rb proteins in primary non‐small cell lung cancers . Int. J. Cancer , 79 , 215 – 220 ( 1998. ). [DOI] [PubMed] [Google Scholar]
  • 24. ) Cairns , P. , Polascik , T. J. , Eby , Y. , Tokino , K. , Califano , J. , Merlo , A. , Mao , L. , Herath , J. , Jenkins , R. , Westra , W. , Rutter , J. L. , Buckler , A. , Gabrielson , E. , Tockman , M. , Cho , K. R. , Hedrick , L. , Bova , G. S. , Isaacs , W. , Koch , W. , Schwab , D. and Sidransky , D.Frequency of homozygous deletion at p16/CDKN2 in primary human tumors . Nat. Genet. , 11 , 210 – 212 ( 1995. ). [DOI] [PubMed] [Google Scholar]
  • 25. ) Reed , A. L. , Califano , J. , Cairns , P. , Westra , W. H. , Jones , R. M. , Koch , W. , Ahrendt , S. , Eby , Y. , Sewell , D. , Nawroz , H. , Bartek , J. and Sidransky , D.High frequency of p16 (CDKN2/MTS‐1/INK4A) inactivation in head and neck squamous cell carcinoma . Cancer Res. , 56 , 3630 – 3633 ( 1996. ). [PubMed] [Google Scholar]
  • 26. ) Herman , J. G. , Graff , J. R. , Myohane , S. , Nelkin , B. D. and Baylin , S. B.Methylation‐specific PCR: a novel PCR assay for methylation status of CpG islands . Proc. Natl. Acad. Set. USA , 93 , 9821 – 9826 ( 1996. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. ) Sakata , K. , Tamura , G. , Maesawa , C. , Suzuki , Y. , Terashima , M. , Satoh , K. , Eda , Y. , Suzuki , A. , Sekiyama , S. and Satodate , R.Loss of heterozygosity on the short arm of chromosome 9 without p16 gene mutation in gastric carcinomas . Jpn. J. Cancer Res. , 86 , 333 – 335 ( 1995. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. ) Gorgoulis , V. G. , Zacharatos , P. , Kotsinas , A. , Liloglou , T. , Kyroudi , A. , Veslemes , M. , Rassidakis , A. , Halazonetis , T. D. , Field , J. K. and Kittas , C.Alterations of p16‐pRb pathway and the chromosome locus 9p21–22 in non‐small‐cell lung carcinomas: relationship with p53 and MDM2 protein expression . Am. J. Pathol. , 144 , 296 – 302 ( 1998. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. ) Mariatos , G. , Gorgoulis , V. G. , Zacharatos , P. , Kotsinas , A. , Vogiatzi , T. , Rassidakis , G. , Foukas , P. , Liloglou , T. , Tiniakos , D. , Angelou , N. , Manolis , E. , Veslemes , M. , Field , J. K. and Kittas , C.Expression of p16INK4A and alterations of the 9p21–23 chromosome region in non‐small‐cell lung carcinomas: relationship with tumor growth parameters and ploidy status . Int. J. Cancer , 89 , 133 – 141 ( 2000. ). [DOI] [PubMed] [Google Scholar]
  • 30. ) Muller , S. Z. , Fong , K. M. , Virtami , A. K. , Geradts , J. , Gazdar , A. F. and Minna , J. D.Aberrant promotor methylation of multiple genes in non‐small cell lung cancers . Cancer Res. , 61 , 249 – 255 ( 2001. ). [PubMed] [Google Scholar]
  • 31. ) Belinsky , S. A. , Palmisano , W. A. , Gilliland , F. D. , Crooks , L. A. , Divine , K. K. , Winters , S. A. , Grimes , M. J. , Harms , H. J. , Tellez , C. S. , Smith , T. M. , Moots , P. P. , Lechner , J. F. , Stidley , C. A. and Crowell , R. E.Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers . Cancer Res. , 62 , 2370 – 2377 ( 2002. ). [PubMed] [Google Scholar]
  • 32. ) Swafford , D. S. , Middleson , S. K. , Palmisano , W. A. , Nikula , K. J. , Tesfaigzi , J. , Baylin , S. B. , Herman , J. G. and Belinsky , S. A.Frequent aberrant methylation of p16INK4A in primary rat lung tumors . Mol. Cell. Biol. , 17 , 1366 – 1374 ( 1997. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33. ) Eguchi , K. , Kanai , Y. , Kobayashi , K. and Hirohashi , S.DNA hypermethylation at the D17S5 locus in non‐small cell lung cancers: its association with smoking history . Cancer Res. , 57 , 4913 – 4915 ( 1997. ). [PubMed] [Google Scholar]
  • 34. ) Lee , Y. W. , Klein , C. B. , Kargacin , B. , Salnikow , K. , Kitahara , J. , Dowjat , W. , Zhitkovich , A. , Christie , N. T. and Costa , M.Carcinogenic nickel silences gene expression by chromatin condensation and DNA methylation: a new model for epigenetic carcinogens . Mol. Cell. Biol. , 15 , 2547 – 2557 ( 1995. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35. ) Belinsky , S. A. , Nikula , K. J. , Baylin , S. B. and Issa , J. P.Increased cytosine DNA‐methyltransferase activity is target‐cell‐specific and an early event in lung cancer . Proc. Natl. Acad. Sci. USA , 93 , 4045 – 4050 ( 1996. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36. ) Okami , K. , Cairns , P. , Westra , W. H. , Linn , J. F. , Ahrendt , S. A. , Wu , L. , Sidransky , D. and Jen , J.Detailed deletion mapping at chromosome 9p21 in non‐small cell lung cancer by microsatellite analysis and fluorescence in situ hybridization . Int. J. Cancer , 74 , 588 – 592 ( 1997. ). [DOI] [PubMed] [Google Scholar]
  • 37. ) Nakayama , T. , Kanedo , M. , Kodama , M. and Nagata , C.Cigarette smoke induces DNA single‐strand breaks in human cells . Nature , 314 , 462 – 464 ( 1985. ). [DOI] [PubMed] [Google Scholar]

Articles from Japanese Journal of Cancer Research : Gann are provided here courtesy of Wiley

RESOURCES